W Y Almawi Selected Research

W Y Almawi Research Topics

Disease

6	Spontaneous Abortion (Miscarriage) 05/2014 - 08/2004
5	Habitual Abortion (Recurrent Miscarriage) 05/2014 - 03/2008
4	Infections 01/2019 - 02/2001
4	Type 2 Diabetes Mellitus (MODY) 12/2013 - 12/2007
3	Obesity 11/2010 - 12/2007
3	Ischemic Stroke 02/2010 - 06/2009
2	Pre-Eclampsia (Preeclampsia) 12/2018 - 01/2018
2	Rheumatoid Arthritis 01/2016 - 09/2015
2	Stroke (Strokes) 07/2009 - 06/2009
2	Sickle Cell Anemia (Hemoglobin S Disease) 03/2009 - 05/2008
2	Chronic Hepatitis C 10/2001 - 02/2001
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2001 - 09/2000
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Hemolysis 12/2018
1	HELLP Syndrome 12/2018
1	Acute Coronary Syndrome 02/2011
1	Delayed Graft Function 04/2010
1	Hypertension (High Blood Pressure) 04/2010
1	Lacunar Stroke 07/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2009
1	Fever (Fevers) 03/2009
1	Acute Chest Syndrome 03/2009
1	Osteomyelitis 05/2008
1	Pregnancy Complications 03/2008
1	Insulin Resistance 12/2007
1	Hyperhomocysteinemia 02/2006
1	Leukocytosis (Pleocytosis) 04/2004
1	Venous Thromboembolism 04/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001

Drug/Important Bio-Agent (IBA)

6	AntibodiesIBA 07/2009 - 02/2001
5	Interleukin-10 (Interleukin 10)IBA 01/2018 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015 - 03/2008
3	Annexin A5IBA 07/2009 - 08/2006
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2009 - 08/2006
3	factor V LeidenIBA 08/2004 - 09/2000
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016 - 05/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2013 - 02/2010
2	Cardiolipins (Cardiolipin)IBA 07/2009 - 11/2007
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2009 - 08/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2009 - 05/2008
2	Protein CIBA 04/2004 - 09/2000
2	Factor V (Coagulation Factor V)IBA 04/2001 - 09/2000
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	EnzymesIBA 12/2018
1	Fas Ligand Protein (Fas Ligand)IBA 12/2018
1	AntigensIBA 01/2016
1	exostosin-2IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2012
1	plasma protein Z (protein Z)IBA 03/2012
1	InterleukinsIBA 02/2011
1	calpain 10IBA 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2010
1	PhosphatidylserinesIBA 07/2009
1	Immunoglobulin G (IgG)IBA 07/2009
1	Immunoglobulin M (IgM)IBA 07/2009
1	AnticoagulantsIBA 07/2009
1	AngiotensinogenIBA 06/2009
1	ReninIBA 06/2009
1	Plasminogen InactivatorsIBA 06/2009
1	Plasminogen Activator Inhibitor 1IBA 06/2009
1	HLA-DRB1*13:01:01 antigenIBA 03/2009
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2008
1	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2008
1	PPAR gammaIBA 12/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2007
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2007
1	Glycoproteins (Glycoprotein)IBA 11/2007
1	CytokinesIBA 12/2006
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2005
1	Calcineurin InhibitorsIBA 09/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2005
1	Prothrombin (Factor II)IBA 08/2004
1	Protein SIBA 04/2004
1	Antithrombin IIIIBA 04/2004
1	NucleotidesIBA 04/2001

Therapy/Procedure

2	Kidney Transplantation 04/2010 - 09/2005
1	Length of Stay 04/2010
1	Therapeutics 04/2010